Ledger.Open graph →
SEC Form D · filed November 10, 2014

Artax Biopharma, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(c)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (14)

Javier Garcia · Cambridge, MADirectorDamia Tormo · Cambridge, MAExec · DirectorGino W. Santini · Cambridge, MADirectorPeter B. Finn · Boston, MAExecRobert W. Armstrong, Ph.D · Cambridge, MADirectorKathryn A. Hall · San Francisco, CAExecAfsaneh Beschloss · Washington, Washington, D.C.DirectorJan W. De Vries, Ph.D · Cambridge, MADirectorAntonio Sierra · Washington, Washington, D.C.Exec · DirectorKarim Fadel · Cambridge, MAExec · DirectorTwo Sigma Principals, LLC · New York, NYDirectorTwo Sigma Investments, LLC · NEW YORK, NYExec · DirectorMatthew W. Clary · CHICAGO, ILDirectorJan W. De Vries, Ph.D · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗